Plus Therapeutics shows positive data for ReSPECT Phase 1 clinical trial in GBM

Press/Media: Press / Media

PeriodNov 19 2020

Media coverage

1

Media coverage

  • TitlePlus Therapeutics shows positive data for ReSPECT Phase 1 clinical trial in GBM
    Media name/outletSeeking Alpha
    CountryUnited States
    Date11/19/20
    PersonsAndrew Brenner